Late Breaking Abstract - Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION

L. Bacharier (Nashville, United States), J. Maspero (Buenos Aires, Argentina), C. Katelaris (Campbelltown, Australia), A. Fiocchi (Rome, Italy), R. Gagnon (Quebec, Canada), I. De Mir-Messa (Barcelona, Spain), T. Guilbert (Cincinnati, United States), D. Jackson (Madison, United States), N. Li (Bridgewater, United States), B. Akinlade (Tarrytown, United States), E. Laws (Bridgewater, United States), L. Mannent (Chilly-Mazarin, France), J. Maloney (Tarrytown, United States), K. Tawo (Bridgewater, United States), F. Khokhar (Tarrytown, United States), M. Hardin (Cambridge, United States), R. Abdulai (Cambridge, United States), D. Lederer (Tarrytown, United States), L. Robinson (Cambridge, United States)

Source: International Congress 2022 – New insights into paediatric asthma diagnosis and management of severe asthma
Session: New insights into paediatric asthma diagnosis and management of severe asthma
Session type: Oral Presentation
Number: 2955

Congress or journal article abstractWebcastPDF journal article, handout or slidesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Bacharier (Nashville, United States), J. Maspero (Buenos Aires, Argentina), C. Katelaris (Campbelltown, Australia), A. Fiocchi (Rome, Italy), R. Gagnon (Quebec, Canada), I. De Mir-Messa (Barcelona, Spain), T. Guilbert (Cincinnati, United States), D. Jackson (Madison, United States), N. Li (Bridgewater, United States), B. Akinlade (Tarrytown, United States), E. Laws (Bridgewater, United States), L. Mannent (Chilly-Mazarin, France), J. Maloney (Tarrytown, United States), K. Tawo (Bridgewater, United States), F. Khokhar (Tarrytown, United States), M. Hardin (Cambridge, United States), R. Abdulai (Cambridge, United States), D. Lederer (Tarrytown, United States), L. Robinson (Cambridge, United States). Late Breaking Abstract - Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION. 2955

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.